Immunovant, Inc. (IMVT)
USD 26.25
(-5.95%)
USD 26.25
(-5.95%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -214.22 Million | -188.19 Million | -106.11 Million | -83.32 Million | -53.35 Million | -28.54 Million |
| Net Income | -259.33 Million | -210.96 Million | -156.73 Million | -107.43 Million | -66.38 Million | -28.59 Million |
| Depreciation & Amortization | 231 Thousand | 193 Thousand | 126 Thousand | 65 Thousand | 21 Thousand | 10 Thousand |
| Deferred income taxes | - | - | - | -282 Thousand | - | - |
| Stock-based compensation | 41.11 Million | 32.29 Million | 34.24 Million | 18.82 Million | 6.96 Million | 1.3 Million |
| Change in working capital | 2.63 Million | -10.85 Million | 15.14 Million | 4.56 Million | 4.8 Million | -474 Thousand |
| Other non-cash items | 41.48 Million | 1.13 Million | 1.1 Million | 933 Thousand | 1.24 Million | -792 Thousand |
| Investing Cash Flow | -360 Thousand | -197 Thousand | -254 Thousand | -210 Thousand | -31 Thousand | -52 Thousand |
| Investments in PPE | -360 Thousand | -197 Thousand | -254 Thousand | -210 Thousand | -31 Thousand | -52 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 472.42 Million | 70.88 Million | 200.12 Million | 383.11 Million | 146.97 Million | 35.58 Million |
| Debt repayment | - | - | - | -3.19 Million | -5 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 472.42 Million | 70.5 Million | 129 Thousand | 319.78 Million | -1.95 Million | - |
| Other Financing Activities | -6.01 Million | 385 Thousand | 200 Million | 66.51 Million | 153.92 Million | 35.58 Million |
| Accounts receivables | -4.55 Million | 11.76 Million | -11.63 Million | -596 Thousand | -83 Thousand | - |
| Accounts payables | 5.78 Million | -17.12 Million | 16.25 Million | 1.25 Million | 967 Thousand | - |
| Inventory | - | - | - | 596 Thousand | 83 Thousand | - |
| Other working capital | 1.4 Million | 5.36 Million | 10.52 Million | 3.31 Million | 3.83 Million | -474 Thousand |
| Cash at beginning of period | 376.53 Million | 493.81 Million | 400.14 Million | 100.57 Million | 6.98 Million | - |
| Cash at end of period | 635.36 Million | 376.53 Million | 493.81 Million | 400.14 Million | 100.57 Million | 6.98 Million |
| Capital Expenditure | -360 Thousand | -197 Thousand | -254 Thousand | -210 Thousand | -31 Thousand | -52 Thousand |
| Effect of forex changes on cash | 993 Thousand | 220 Thousand | -92 Thousand | - | - | - |
| Net cash flow / Change in cash | 258.83 Million | -117.28 Million | 93.67 Million | 299.57 Million | 93.58 Million | 6.98 Million |
| Free Cash Flow | -214.58 Million | -188.39 Million | -106.36 Million | -83.53 Million | -53.38 Million | -28.59 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -75.31 Million | -259.33 Million | -51.41 Million | -58.66 Million | -73.93 Million | -210.96 Million |
| Depreciation & Amortization | 64 Thousand | 231 Thousand | 525 Thousand | 56 Thousand | 53 Thousand | 193 Thousand |
| Deferred income taxes | 36.13 Million | - | -11.27 Million | - | -24.86 Million | - |
| Stock-based compensation | 9679.00 | 41.11 Million | 10.19 Thousand | 10.5 Thousand | 10.68 Thousand | 32.29 Million |
| Change in working capital | 5.62 Million | 2.63 Million | -6.25 Million | -12.27 Million | 15.53 Million | -10.85 Million |
| Other non-cash items | 10.78 Million | 41.48 Million | 11.09 Million | 293 Thousand | 25.15 Million | 1.13 Million |
| Investing Cash Flow | -150 Thousand | -360 Thousand | -131 Thousand | -34 Thousand | -45 Thousand | -197 Thousand |
| Investments in PPE | -150 Thousand | -360 Thousand | -131 Thousand | -34 Thousand | -45 Thousand | -197 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 1.54 Million | 472.42 Million | 469.84 Million | 148 Thousand | 890 Thousand | 70.88 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 474.29 Million | 472.42 Million | -2.9 Million | 148 Thousand | 890 Thousand | 70.5 Million |
| Other Financing Activities | -472.74 Million | -6.01 Million | 472.74 Million | 148.00 | 890.00 | 385 Thousand |
| Accounts receivables | -4.12 Million | -4.55 Million | 266 Thousand | -561 Thousand | -142 Thousand | 11.76 Million |
| Accounts payables | 3.39 Million | 5.78 Million | -3.7 Million | -18.91 Million | 25.01 Million | -17.12 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | 6.35 Million | 1.4 Million | -2.81 Million | 7.2 Million | -24.86 Million | 5.36 Million |
| Cash at beginning of period | 690.93 Million | 376.53 Million | 269.92 Million | 329.96 Million | 376.53 Million | 493.81 Million |
| Cash at end of period | 635.36 Million | 635.36 Million | -51.41 Million | 269.92 Million | 329.96 Million | 376.53 Million |
| Capital Expenditure | -150 Thousand | -360 Thousand | -131 Thousand | -34 Thousand | -45 Thousand | -197 Thousand |
| Effect of forex changes on cash | 2.73 Million | 993 Thousand | -1.6 Million | -86 Thousand | -47 Thousand | 220 Thousand |
| Net cash flow / Change in cash | -55.57 Million | 258.83 Million | -321.34 Million | -60.03 Million | -46.57 Million | -117.28 Million |
| Free Cash Flow | -59.84 Million | -214.58 Million | -47.22 Million | -60.09 Million | -47.41 Million | -188.39 Million |
CDMNF
ENEL
AAL
NPN
JAM
3702